STUDY OF RELAPSING-REMITTING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS SJL MOUSE MODEL USING MION-46L ENHANCED IN-VIVO MRI - EARLY HISTOPATHOLOGICAL CORRELATION
S. Xu et al., STUDY OF RELAPSING-REMITTING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS SJL MOUSE MODEL USING MION-46L ENHANCED IN-VIVO MRI - EARLY HISTOPATHOLOGICAL CORRELATION, Journal of neuroscience research, 52(5), 1998, pp. 549-558
MION-46L, a superparamagnetic iron oxide contrast agent, was investiga
ted for its ability to increase the sensitivity of in vivo 3D MRI in t
he detection of brain lesions in a chronic experimental allergic encep
halomyelitis (crEAE) mouse model. Lesion conspicuity on postcontrast 3
D MRI was dramatically enhanced as compared to precontrast images corr
esponding to areas of inflammatory and demyelinating lesions. MION-46L
could be detected on Prussian blue iron stain in the vascular endothe
lium, the perivascular space, and in macrophages within perivascular c
uffs and areas of inflammation and demyelination, By taking advantage
of the MION-46L induced macroscopic susceptibility effect, acute early
lesions measuring only 100 mu m in diameter could be detected. MION-4
6L enhanced MRI may be used to 1) provide a unique sensitivity in EAE
lesion detection and correlate imaging to histopathology; 2) help to u
nderstand EAE lesion development and its underlying pathophysiology; a
nd 3) eventually assist in preclinical screening of new experimental t
herapies directed at patients with multiple sclerosis (MS). (C) 1998 W
iley-Liss, Inc. dagger.